Topical cyclosporine 0.05% impact on pterygium recurrence in patients undergoing pterygium surgery
Phase 3
Recruiting
- Conditions
- Pterygium.Pterygium of eyeH11.0
- Registration Number
- IRCT20160919029871N4
- Lead Sponsor
- Guilan University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
Patients with a Pterygium larger than 3 mm at horizontal width over the cornea on Slit-lamp exam who are candidates for surgery
Exclusion Criteria
Patients with previous pterygium recurrence, pseudo-pterygium
Pregnant and breastfeeding mothers, systemic disease like diabetes and heart disease
Ocular surface disease like keratitis or dry eye or conjunctivitis
Prior ocular surgery within 6 months
Hypersensitivity to cyclosporine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical inflammation grading and pterygium recurrence. Timepoint: Day 1, 3, 7, 30, 90 and 6 months after surgery. Method of measurement: Clinical examination.
- Secondary Outcome Measures
Name Time Method